25 August 2020 - More insights extracted by the MAESTrO Team from the outcomes from the July 2020 PBAC meeting. ...
25 August 2020 - Some outcomes are not clear. ...
17 July 2020 - The Public Summary Documents (first time rejections and deferrals) from the March 2020 PBAC meeting are now ...
13 July 2020 - In a rare dual-review process, two independent advisory committees to the Australian Minister for Health recommend reimbursement ...
19 June 2020 - There is actually only one recommendation. ...
27 April 2020 - Did the PBAC give Sanofi the run around? ...
28 April 2020 - Has Novo Nordisk shot itself in the foot? ...
24 April 2020 - The recommendations from the March 2020 PBAC meeting are now available. ...
26 March 2020 - Additional insights from the second round of public summary documents (first time rejections and deferrals). ...
25 March 2020 - Insights from the second round of public summary documents (first time rejections and deferrals). ...
13 February 2020 - The outcomes from the December 2019 PBAC intracycle meeting are now available. ...
7 January 2020 - Analysis and insights from the November 2019 PBAC meeting. ...
20 December 2019 - PBAC responds to a minor submission from National Aboriginal Community Controlled Health Organisation. ...
21 December 2019 - The recommendations from the November 2019 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available. ...
8 December 2019 - It feels like ‘bugs under the skin’ 24/7, but a new drug that offers hope to sufferers ...